Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130192614> ?p ?o ?g. }
- W2130192614 endingPage "2449" @default.
- W2130192614 startingPage "2436" @default.
- W2130192614 abstract "Abstract On the basis of enhanced tumor accumulation and bone affinity, gallium compounds are under development as anticancer and antimetastatic agents. In this study, we analyzed molecular targets of one of the lead anticancer gallium complexes [KP46, Tris(8-quinolinolato)gallium(III)] focusing on colon and lung cancer. Within a few hours, KP46 treatment at low micromolar concentrations induced cell body contraction and loss of adhesion followed by prompt cell decomposition. This rapid KP46-induced cell death lacked classic apoptotic features and was insensitive toward a pan–caspase inhibitor. Surprisingly, however, it was accompanied by upregulation of proapoptotic Bcl-2 family members. Furthermore, a Bax- but not a p53-knockout HCT-116 subline exhibited significant KP46 resistance. Rapid KP46-induced detachment was accompanied by downregulation of focal adhesion proteins, including several integrin subunits. Loss of integrin-β1 and talin plasma membrane localization corresponded to reduced binding of RGD (Arg–Gly–Asp) peptides to KP46-treated cells. Accordingly, KP46-induced cell death and destabilization of integrins were enhanced by culture on collagen type I, a major integrin ligand. In contrast, KP46-mediated adhesion defects were partially rescued by Mg2+ ions, promoting integrin-mediated cell adhesion. Focal adhesion dynamics are regulated by calpains via cleavage of multiple cell adhesion molecules. Cotreatment with the cell-permeable calpain inhibitor PD150606 diminished KP46-mediated integrin destabilization and rapid cell death induction. KP46 treatment distinctly inhibited HCT-116 colon cancer xenograft in vivo by causing reduced integrin plasma membrane localization, tissue disintegration, and intense tumor necrosis. This study identifies integrin deregulation via a calpain-mediated mechanism as a novel mode of action for the anticancer gallium compound KP46. Mol Cancer Ther; 13(10); 2436–49. ©2014 AACR." @default.
- W2130192614 created "2016-06-24" @default.
- W2130192614 creator A5000751299 @default.
- W2130192614 creator A5000911713 @default.
- W2130192614 creator A5005367552 @default.
- W2130192614 creator A5008389614 @default.
- W2130192614 creator A5012350585 @default.
- W2130192614 creator A5013959435 @default.
- W2130192614 creator A5033593586 @default.
- W2130192614 creator A5034302513 @default.
- W2130192614 creator A5038430837 @default.
- W2130192614 creator A5040213749 @default.
- W2130192614 creator A5043913136 @default.
- W2130192614 creator A5064398880 @default.
- W2130192614 creator A5088586100 @default.
- W2130192614 creator A5090667589 @default.
- W2130192614 date "2014-10-01" @default.
- W2130192614 modified "2023-09-30" @default.
- W2130192614 title "Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46" @default.
- W2130192614 cites W1532560676 @default.
- W2130192614 cites W1576773659 @default.
- W2130192614 cites W1608259439 @default.
- W2130192614 cites W1638976038 @default.
- W2130192614 cites W1762614886 @default.
- W2130192614 cites W1842269155 @default.
- W2130192614 cites W1970631293 @default.
- W2130192614 cites W1978779046 @default.
- W2130192614 cites W1981432984 @default.
- W2130192614 cites W1981910382 @default.
- W2130192614 cites W1985233650 @default.
- W2130192614 cites W1990582582 @default.
- W2130192614 cites W1993563120 @default.
- W2130192614 cites W2009681528 @default.
- W2130192614 cites W2012277863 @default.
- W2130192614 cites W2014064141 @default.
- W2130192614 cites W2019208652 @default.
- W2130192614 cites W2023185574 @default.
- W2130192614 cites W2023430483 @default.
- W2130192614 cites W2023623233 @default.
- W2130192614 cites W2026186604 @default.
- W2130192614 cites W2030864103 @default.
- W2130192614 cites W2033019313 @default.
- W2130192614 cites W2036409173 @default.
- W2130192614 cites W2038062002 @default.
- W2130192614 cites W2051238023 @default.
- W2130192614 cites W2051834063 @default.
- W2130192614 cites W2053458496 @default.
- W2130192614 cites W2055838895 @default.
- W2130192614 cites W2063328565 @default.
- W2130192614 cites W2075956249 @default.
- W2130192614 cites W2087625365 @default.
- W2130192614 cites W2094469836 @default.
- W2130192614 cites W2100773611 @default.
- W2130192614 cites W2103132902 @default.
- W2130192614 cites W2113304856 @default.
- W2130192614 cites W2120078554 @default.
- W2130192614 cites W2130527861 @default.
- W2130192614 cites W2139866712 @default.
- W2130192614 cites W2145139438 @default.
- W2130192614 cites W2147000598 @default.
- W2130192614 cites W2150852167 @default.
- W2130192614 cites W2157732685 @default.
- W2130192614 cites W2323554346 @default.
- W2130192614 doi "https://doi.org/10.1158/1535-7163.mct-14-0087" @default.
- W2130192614 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25082959" @default.
- W2130192614 hasPublicationYear "2014" @default.
- W2130192614 type Work @default.
- W2130192614 sameAs 2130192614 @default.
- W2130192614 citedByCount "22" @default.
- W2130192614 countsByYear W21301926142015 @default.
- W2130192614 countsByYear W21301926142016 @default.
- W2130192614 countsByYear W21301926142017 @default.
- W2130192614 countsByYear W21301926142018 @default.
- W2130192614 countsByYear W21301926142019 @default.
- W2130192614 countsByYear W21301926142020 @default.
- W2130192614 countsByYear W21301926142021 @default.
- W2130192614 countsByYear W21301926142022 @default.
- W2130192614 countsByYear W21301926142023 @default.
- W2130192614 crossrefType "journal-article" @default.
- W2130192614 hasAuthorship W2130192614A5000751299 @default.
- W2130192614 hasAuthorship W2130192614A5000911713 @default.
- W2130192614 hasAuthorship W2130192614A5005367552 @default.
- W2130192614 hasAuthorship W2130192614A5008389614 @default.
- W2130192614 hasAuthorship W2130192614A5012350585 @default.
- W2130192614 hasAuthorship W2130192614A5013959435 @default.
- W2130192614 hasAuthorship W2130192614A5033593586 @default.
- W2130192614 hasAuthorship W2130192614A5034302513 @default.
- W2130192614 hasAuthorship W2130192614A5038430837 @default.
- W2130192614 hasAuthorship W2130192614A5040213749 @default.
- W2130192614 hasAuthorship W2130192614A5043913136 @default.
- W2130192614 hasAuthorship W2130192614A5064398880 @default.
- W2130192614 hasAuthorship W2130192614A5088586100 @default.
- W2130192614 hasAuthorship W2130192614A5090667589 @default.
- W2130192614 hasBestOaLocation W21301926141 @default.
- W2130192614 hasConcept C104317684 @default.
- W2130192614 hasConcept C127561419 @default.
- W2130192614 hasConcept C1491633281 @default.
- W2130192614 hasConcept C151166631 @default.